These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15944305)

  • 1. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.
    Santosuosso M; Zhang X; McCormick S; Wang J; Hitt M; Xing Z
    J Immunol; 2005 Jun; 174(12):7986-94. PubMed ID: 15944305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
    Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
    Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
    Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
    Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.
    Jeyanathan M; Mu J; McCormick S; Damjanovic D; Small CL; Shaler CR; Kugathasan K; Xing Z
    Am J Respir Crit Care Med; 2010 Apr; 181(8):862-72. PubMed ID: 20019338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization.
    Santosuosso M; McCormick S; Roediger E; Zhang X; Zganiacz A; Lichty BD; Xing Z
    J Immunol; 2007 Feb; 178(4):2387-95. PubMed ID: 17277145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
    Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
    J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
    Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
    J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
    Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
    Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
    Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
    Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung.
    Jeyanathan M; Mu J; Kugathasan K; Zhang X; Damjanovic D; Small C; Divangahi M; Petrof BJ; Hogaboam CM; Xing Z
    J Immunol; 2008 Oct; 181(8):5618-26. PubMed ID: 18832720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis.
    Mu J; Jeyanathan M; Small CL; Zhang X; Roediger E; Feng X; Chong D; Gauldie J; Xing Z
    Mol Ther; 2009 Jun; 17(6):1093-100. PubMed ID: 19319120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
    Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
    Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
    Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
    Tchilian E; Ahuja D; Hey A; Jiang S; Beverley P
    Vaccine; 2013 Sep; 31(41):4624-31. PubMed ID: 23896422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
    Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell-independent protective immunity.
    Mu J; Jeyanathan M; Shaler CR; Horvath C; Damjanovic D; Zganiacz A; Kugathasan K; McCormick S; Xing Z
    J Gene Med; 2010 Aug; 12(8):693-704. PubMed ID: 20694950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
    Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.